# Erythropoietin in Acute Myocardial Infarction

> **NCT00149058** · PHASE2 · UNKNOWN · sponsor: **Hammersmith Hospitals NHS Trust** · enrollment: 124 (—)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Erythropoietin

## Key facts

- **NCT ID:** NCT00149058
- **Lead sponsor:** Hammersmith Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2008-01
- **Target enrollment:** 124 (—)
- **Last updated:** 2005-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00149058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00149058, "Erythropoietin in Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00149058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*